Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma

被引:8
|
作者
Locke, Jennifer A. [1 ]
Hamidizadeh, Reza [1 ]
Kassouf, Wassim [2 ]
Rendon, Ricardo A. [3 ]
Bell, David [3 ]
Izawa, Jonathan [4 ]
Chin, Joseph [4 ]
Kapoor, Anil [5 ]
Shayegen, Bobby [5 ]
Lattouf, Jean-Baptiste [6 ]
Saad, Fred [6 ]
Lacombe, Louis [7 ]
Fradet, Yves [7 ]
Fairey, Adrien S. [8 ]
Jacobson, Niels-Eric [8 ]
Drachenberg, Darrel E. [9 ]
Cagiannos, Ilias [10 ]
So, Alan I. [1 ]
Black, Peter C. [1 ]
机构
[1] Univ British Columbia, Vancouver, BC, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Dalhousie Univ, Halifax, NS, Canada
[4] Univ Western Ontario, London, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] Univ Montreal, Montreal, PQ, Canada
[7] Laval Univ, Quebec City, PQ, Canada
[8] Univ Alberta, Edmonton, AB, Canada
[9] Univ Manitoba, Winnipeg, MB, Canada
[10] Univ Ottawa, Ottawa, ON, Canada
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2018年 / 12卷 / 08期
关键词
RADICAL NEPHROURETERECTOMY; TUMOR LOCATION; BLADDER-TUMORS; IMPACT; SURVIVAL; OUTCOMES; MULTIFOCALITY; ASSOCIATION;
D O I
10.5489/cuaj.5377
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of all urothelial tumours. Due to its rarity, evidence regarding postoperative surveillance is lacking. The objective of this study was to develop a post-radical nephroureterectomy (RNU) surveillance protocol based on recurrence patterns in a large, multi-institutional cohort of patients. Methods: Retrospective clinical and pathological data were collected from 1029 patients undergoing RNU over a 15-year period (1994-2009) at 10 Canadian academic institutions. A multivariable model was used to identify prognostic clinicopathological factors, which were then used to define risk categories. Risk-based surveillance guidelines were proposed based on actual recurrence patterns. Results: Overall, 555 (49.9%) patients developed recurrence, including 289 (25.9%) in the urothelium and 266 (23.9%) with loco-regional and distant recurrences. Based on multivariable analysis, three risk groups were identified: 1) low-risk patients with pTa-T1, pN0 disease, and no adverse histological features (high tumour grade, lymphovascular invasion [LVI], tumour multifocality); 2) intermediate-risk patients with pTa-T1, pN0 disease with one or more of the adverse histological features; and 3) high-risk patients with a >= pT2 tumour and/or nodal involvement. Low-, intermediate-, and high-risk patients were free of urothelial recurrence at three years in 72%, 66%, and 63%, respectively, and free of regional/distant recurrence in 93%, 87%, and 62%, respectively. The risks of loco-regional and distant recurrences (p<0.0001) and time to death (p<0.0001) were significantly different between the low-, intermediate-, and high-risk patients. Conclusions: Based on recurrence patterns in a large, multicentre patient cohort, we have proposed an evidence-based, risk-adapted post-RNU surveillance protocol.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [21] Genomic Characterization of Upper Tract Urothelial Carcinoma
    Sfakianos, John P.
    Cha, Eugene K.
    Iyer, Gopa
    Scott, Sasinya N.
    Zabor, Emily C.
    Shah, Ronak H.
    Ren, Qinghu
    Bagrodia, Aditya
    Kim, Philip H.
    Hakimi, A. Ari
    Ostrovnaya, Irina
    Ramirez, Ricardo
    Hanrahan, Aphrothiti J.
    Desai, Neil B.
    Sun, Arony
    Pinciroli, Patrizia
    Rosenberg, Jonathan E.
    Dalbagni, Guido
    Schultz, Nikolaus
    Bajorin, Dean F.
    Reuter, Victor E.
    Berger, Michael F.
    Bochner, Bernard H.
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Coleman, Jonathan A.
    EUROPEAN UROLOGY, 2015, 68 (06) : 970 - 977
  • [22] Prognostic factors of upper tract urothelial carcinoma
    Elalouf, V.
    Klap, J.
    Delongcharnps, N. -B.
    Conquy, S.
    Sibony, M.
    Saighi, D.
    Peyromaure, M.
    Flam, T.
    Zerbib, M.
    Xylinas, E.
    PROGRES EN UROLOGIE, 2013, 23 (16): : 1382 - 1388
  • [23] The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
    Zhang, Xiaodi
    Wang, Ping
    Qi, Kaiyan
    Qiao, Qiao
    Jiang, Yuanjun
    CANCER MEDICINE, 2021, 10 (22): : 8079 - 8090
  • [24] Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma
    Chen, Han
    Wang, Ming
    Weng, Tonghui
    Wei, Yu
    Yang, Lei
    Ren, Ke
    Tang, Zhaobing
    Gou, Xin
    UROLOGIA INTERNATIONALIS, 2022, 106 (02) : 186 - 194
  • [25] Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival
    Milojevic, Bogomir
    Dzamic, Zoran
    Bojanic, Nebojsa
    Durutovic, Otas
    Janicic, Aleksandar
    Kajmakovic, Boris
    Milojevic, Isidora Grozdic
    Bumbasirevic, Uros
    Grubor, Nikola
    Grujicic, Sandra Sipetic
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (05) : 831 - 838
  • [26] Radiomics-Based Computed Tomography Urogram Approach for the Prediction of Survival and Recurrence in Upper Urinary Tract Urothelial Carcinoma
    Alqahtani, Abdulsalam
    Bhattacharjee, Sourav
    Almopti, Abdulrahman
    Li, Chunhui
    Nabi, Ghulam
    CANCERS, 2024, 16 (18)
  • [27] Comparison of European and American Guidelines for Upper Tract Urothelial Carcinoma: How Are They different?
    Solano, Catalina
    Corrales, Mariela
    Keller, Etienne-Xavier
    Kwok, Jia-Lun
    Panthier, Frederic
    Doizi, Steeve
    Traxer, Olivier
    JOURNAL OF ENDOUROLOGY, 2024, 38 (05) : 488 - 498
  • [28] Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study
    Bjornsson, Oddur
    Jonsson, Eirikur
    Gudmundsson, Eirikur Orri
    Marteinsson, Valur Thor
    Nikulasson, Sigfus Thor
    Gudjonsson, Sigurdur
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (03) : 197 - 202
  • [29] The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma
    Al Awamlh, Bashir Al Hussein
    Shoag, Jonathan E.
    Basourakos, Spyridon P.
    Lewicki, Patrick J.
    Posada, Line
    Ma, Xiaoyue
    Raman, Jay D.
    Shariat, Shahrokh F.
    Scherr, Douglas
    UROLOGY, 2021, 154 : 127 - 135
  • [30] Lymph node dissection for upper tract urothelial carcinoma: A systematic review
    Chan, Vinson Wai-Shun
    Wong, Chris Ho Ming
    Yuan, Yuhong
    Teoh, Jeremy Yuen-Chun
    ARAB JOURNAL OF UROLOGY, 2021, 19 (01) : 37 - 45